One journey, many lenses
Gaining a granular view of the patient journey is critical to life sciences commercialization in today’s patient-centric world, informing everything from product development to market access and post-launch management.
Unfortunately, patient journey efforts are often conducted in a fragmented fashion, with different teams employing different methodologies and data sources, depriving companies of a more comprehensive view of the barriers and drivers impacting their brands.
At Decision Resources Group, we’re rethinking the way we trace the patient journey with the aim of capturing the larger picture, in greater detail, so that our customers can better serve their customers.
How we help
At DRG, we examine the patient journey through multiple lenses in order to provide a granular and insights-rich view of the patient journey:
Clinical Journey
- Treatment and referral patterns
- Time to diagnosis
- Sites of care
- Line of therapy progression
Cost Journey
- Impact of cost burden and market access factors on treatment decisions and behaviors
Attitudinal Journey
- What patients are feeling at each stage in the treatment journey
- Connections with patient behaviors such as adoption, adherence, discontinuation and switching
- HCP attitudes
Informational Journey
- Channels, devices and sites sourced for health and medical info
We partner with clients on patient journey analyses to help enhance commercial activities, including:
- Sales force optimization
- Patient engagement
- Physician engagement
- Payer value communication
- Segmentation and targeting
- Adherence and switching management
- Opportunity assessment
- And more
Diverse data sources
The power of the integrated patient journey approach lies in the combination of quantitative and qualitative data sources to reveal key intervention points and opportunities for differentiating products across multiple stakeholder audiences.
Online behavioral data
Primary market research
Social data
Secondary market research
Diverse data sources power an integrated patient journey
Claims
- 26 billion claims
- Visibility into 300+ million patients (over 3 years)
- 2+ million healthcare providers
- 98% of 750 U.S. payers, real-time updates
- Hospitals, physician offices, ASCs, pharmacies, long-term care, nursing facilities
Online behavioral data
- Search data
- Clickstream data
Electronic health records
- Visibility into 100+ million patients (over 3 years)
- Diagnoses, diagnostic tests, assessments, vaccines, vitals, Rx
Primary market research
- 25+ countries
- 25+ specialities
- 50+ therapeutic areas
Social data
- Anonymized social conversation data from public social platforms, online communities and message boards
Secondary market research
- Public health and demographic data sets
- Formulary coverage
What our clients say
“Our previous patient journey work was conducted in typical fashion – qualitative interviews with patients, maybe a quantitative study, but we really needed to understand the emotions patients were experiencing at each stage in order to identify messaging that resonates in order to better support patients and keep them on that journey longer. Having that voice-of-the-patient lexicon was huge – a lot of what our marketing team puts out now utilizes the language patients are using online, as opposed to the more clinical language encouraged by medical, legal and regulatory. Patients don’t want to read language that they’re not using in the context of their day-to-day.”
Head of market intelligence at a mid-sized pharma
Resources
Want to learn more?
Contact us to connect with a DRG specialist on how we can enhance your patient journey mapping: